COVID-19 / Influenza A&B
Rapid Combo Test Kit
Detect and differentiate SARS-CoV-2, Influenza A, and Influenza B in a single test — results in as fast as 15 minutes at the point of care.
By WELLlife™ / Wondfo • 25 Tests/Box • 510(k) Cleared
25 Tests Per Box
MFR#: WV01P0002
Why This Test Kit?
Accurate, fast, and simple — everything your practice needs to diagnose respiratory infections at the point of care this season.
Get clear, easy-to-read results in as fast as 15 minutes. No lab send-outs needed for initial screening.
Simultaneously detects and differentiates SARS-CoV-2, Influenza A, and Influenza B from a single nasal swab.
Authorized for use at the point of care under CLIA Certificate of Waiver. Trusted by thousands of practices.
Simple, direct shallow anterior nasal swab collection. Comfortable for patients, efficient for staff.
25 sealed test cassettes, sterile nasal swabs, pre-filled extraction tubes, tube tips, holders, and full instructions.
Clear positive/negative line indicators. Reference guide and healthcare provider fact sheet included in every box.
What's In The Box
Each box comes with everything needed for 25 complete tests — no additional supplies required.
Technical Specifications
Simple 3-Step Process
From sample collection to results in minutes — designed for efficiency at the point of care.
Collect Sample
Perform a direct, shallow anterior nasal swab on the symptomatic patient. Quick and comfortable.
Run the Test
Insert swab into the pre-filled extraction tube, mix, then apply drops to the test cassette.
Read Results
Interpret clear line indicators within 15-20 minutes. Positive, negative, or invalid — no ambiguity.
Stock Up for Flu & COVID Season
Don't let your practice run short during peak respiratory illness season. Order your test kits today and ensure you're prepared for every patient visit.
Need volume pricing for your facility? Contact us directly for institutional rates.
FDA Disclaimer: This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories. It is authorized for the detection of proteins from SARS-CoV-2, Influenza A, and Influenza B and not for any other viruses or pathogens. The test is authorized for use at the Point of Care (POC) in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.